Peter S. Roddy
Plus aucun poste en cours
Profil
Peter S.
Roddy served as the Chief Financial Officer at COR Therapeutics, Inc. from 2002 to 2012.
He also served as the Chief Financial Officer & Vice President at Cassava Sciences, Inc. from 2002 to 2017.
Additionally, he was the Lead Independent Director at Aspira Women's Health, Inc. from 2010 to 2016 and the Chief Accounting Officer & Senior Vice President at Cytokinetics, Inc. from 2017 to 2019.
Prior to these roles, he was a Director at The Association of Bioscience Financial Officers.
Roddy received his undergraduate degree from the University of California, Berkeley.
Anciens postes connus de Peter S. Roddy
| Sociétés | Poste | Fin |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Comptroller/Controller/Auditor | 15/05/2019 |
| CASSAVA SCIENCES, INC. | Directeur Financier/CFO | 09/03/2017 |
| ASPIRA WOMEN'S HEALTH INC. | Directeur/Membre du Conseil | 16/06/2016 |
COR Therapeutics, Inc.
 COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | Directeur Financier/CFO | 01/01/2012 |
The Association of Bioscience Financial Officers
 The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Directeur/Membre du Conseil | - |
Formation de Peter S. Roddy
| University of California, Berkeley | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| CASSAVA SCIENCES, INC. | Health Technology |
| ASPIRA WOMEN'S HEALTH INC. | Health Technology |
| CYTOKINETICS, INCORPORATED | Health Technology |
| Entreprise privées | 2 |
|---|---|
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | Health Technology |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Commercial Services |
